These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34052963)

  • 1. A Comparison of Attitudes, Comfort, and Knowledge of Clozapine Among Two Diverse Samples of US Psychiatrists.
    Cotes RO; Janjua AU; Broussard B; Lazris D; Khan A; Jiao Y; Kopelovich SL; Goldsmith DR
    Community Ment Health J; 2022 Apr; 58(3):517-525. PubMed ID: 34052963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comfort Level and Barriers to the Appropriate Use of Clozapine: a Preliminary Survey of US Psychiatric Residents.
    Singh B; Hughes AJ; Roerig JL
    Acad Psychiatry; 2020 Feb; 44(1):53-58. PubMed ID: 31713078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatrists' attitude towards and knowledge of clozapine treatment.
    Nielsen J; Dahm M; Lublin H; Taylor D
    J Psychopharmacol; 2010 Jul; 24(7):965-71. PubMed ID: 19164499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey.
    Daod E; Krivoy A; Shoval G; Zubedat S; Lally J; Vadas L; Weizman A; Reshef A; Bloch B
    Psychiatry Res; 2019 May; 275():155-161. PubMed ID: 30913436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program.
    Tang Y; Horvitz-Lennon M; Gellad WF; Lave JR; Chang CH; Normand SL; Donohue JM
    Psychiatr Serv; 2017 Jun; 68(6):579-586. PubMed ID: 28196460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
    James BO; Omoaregba JO; Raji SO; Imishue OE; Okonoda KM; Nyamali YI; Famuyiwa PA; Correll CU
    Psychiatry Res; 2017 Feb; 248():134-139. PubMed ID: 28063386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey on barriers to psychiatrists' use of clozapine for young people in Scotland and suggestions for reducing these.
    Walker G; Lang J; Smith H
    PLoS One; 2024; 19(6):e0304996. PubMed ID: 38900758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing clozapine under-prescribing and barriers to initiation: a psychiatrist, advanced practice provider, and trainee survey.
    Leung JG; Cusimano J; Gannon JM; Milgrom O; Valcourt SC; Stoklosa JB; Kemp M; Olsufka W; Vickery PB; Nichols SD; Crouse EL; Paxos C; Johnson EK; Palmer BA
    Int Clin Psychopharmacol; 2019 Sep; 34(5):247-256. PubMed ID: 31107831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
    Velligan DI; Carroll C; Lage MJ; Fairman K
    Psychiatr Serv; 2015 Feb; 66(2):127-33. PubMed ID: 25321616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iranian psychiatrists' attitude towards clozapine use for patients with treatment-resistant schizophrenia: a nationwide survey.
    Rezaie L; Nazari A; Safari-Faramani R; Shohaimi S; Khazaie H
    BMC Psychiatry; 2022 Aug; 22(1):534. PubMed ID: 35933353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ever-growing case for clozapine in the treatment of schizophrenia: an obligation for psychiatrists and psychiatry.
    Bittner RA; Reif A; Qubad M
    Curr Opin Psychiatry; 2023 Jul; 36(4):327-336. PubMed ID: 37222196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
    Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
    Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription practices and attitude of psychiatrists towards clozapine: A survey of psychiatrists from India.
    Grover S; Balachander S; Chakarabarti S; Avasthi A
    Asian J Psychiatr; 2015 Dec; 18():57-65. PubMed ID: 26498722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Every patient with treatment resistant schizophrenia should know the meaning of the term 'clozapine'.
    Nielsen J
    Acta Psychiatr Scand; 2014 Aug; 130(2):155-6. PubMed ID: 24845026
    [No Abstract]   [Full Text] [Related]  

  • 16. Addressing Barriers to Clozapine Underutilization: A National Effort.
    Kelly DL; Freudenreich O; Sayer MA; Love RC
    Psychiatr Serv; 2018 Feb; 69(2):224-227. PubMed ID: 29032704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizational Characteristics of Veterans Affairs Clinics With High and Low Utilization of Clozapine.
    Gören JL; Rose AJ; Engle RL; Smith EG; Christopher ML; Rickles NM; Semla TP; McCullough MB
    Psychiatr Serv; 2016 Nov; 67(11):1189-1196. PubMed ID: 27301765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting clozapine prescribing patterns in the east and west?
    Chong SA; Remington GJ; Lee N; Mahendran R
    Ann Acad Med Singap; 2000 Jan; 29(1):75-8. PubMed ID: 10748970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.